BuChE-IN-20 is a selective butyrylcholinesterase (hBuChE) inhibitor (IC50 = 0.13 µM) with BBB permeability. BuChE-IN-20 is a L-Tryptophan derivative. BuChE-IN-20 possesses neuroprotective properties by inhibiting the production of nitric oxide (NO) and lowering the levels of ROS. BuChE-IN-20 is proficient in inhibiting the self-aggregation of amyloid-beta (Abeta) peptides. BuChE-IN-20 can be used in research for Alzheimers disease[1].
Molekulargewicht:
484.56
Formel:
C29H29FN4O2
Target-Kategorie:
Amyloid-beta,Cholinesterase (ChE),Interleukin Related,NOD-like Receptor (NLR),Reactive Oxygen Species (ROS)
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
